COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Cambridge Biomedical Research Centre "Distinguished Visitors" 2015 Lecture Series > “The AML Genome(s): Mutations in Four Dimensions”
“The AML Genome(s): Mutations in Four Dimensions”Add to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Sylvie Robinson. Dr. Timothy Ley received his BA from Drake University, his MD degree from Washington University Medical School, and performed his internal medicine residency at Massachusetts General Hospital. He completed fellowships in Hematology and Oncology at the NIH and at Washington University, and jointed the faculty at Washington University in St. Louis in 1986. He now holds the Lewis T. and Rosalind B. Apple Chair in Oncology, is Professor of Medicine and of Genetics at Washington University, and serves as Director of the Stem Cell Biology Section in the Department of Medicine, and Associate Director of The Genome Institute (for Cancer Genomics). Ley is a past president of the American Society for Clinical Investigation, past treasurer of the American Association of Physicians, a fellow of AAAS and the American Academy of Arts and Sciences, and a member of the Institute of Medicine. He was the 2012 recipient of the E. Donnall Thomas Prize from the American Society of Hematology. He has developed approaches to reactivate fetal hemoglobin synthesis for patients with hemoglobinopathies, defined the role of the perforin/granzyme system for the function of cytotoxic and regulatory T cells, and has performed pioneering studies that have defined the genomics of acute myeloid leukemia. He led the team at Washington University that sequenced the first human cancer genomes. He has written extensively about the physician-scientist career path, and was a key advocate for establishing the extramural Loan Repayment Programs at the NIH . He has mentored more than 50 pre- and post-doctoral fellows in his laboratory; most hold research positions in academic medicine or pharmaceutical companies. This talk is part of the Cambridge Biomedical Research Centre "Distinguished Visitors" 2015 Lecture Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCambridge Zero Carbon Society ORGANOID Technology Courses ICE Summer Festival Global Challenges Research Fund (GCRF) FERSA - All Events SciBarOther talksMechanical properties of cells or cell components on the micro- and nanometer scale Oncological Imaging: introduction and non-radionuclide techniques & radionuclide techniques How to Design a 21st Century Economy - with Kate Raworth What is the Market Potential of Multilingualism? Acceleration of tropical cyclogenesis by self-aggregation feedbacks |